https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6678&f=G&l=50&d=PTXT&p=134&S1=20210817&OS=20210817&RS=20210817
Related Posts
Albireo’s Bylvay Shows Further Evidence Of Sustained, Durable Effect In Pediatric Liver Disease Study
Albireo Pharma Inc (NASDAQ:ALBO) has announced pooled analysis from Phase 3 PEDFIC studies with Bylvay (odevixibat) and advancement in the characterization…
DOJ Mulls Lawsuit Blocking UnitedHealth, Change HealthCare Deal: Report
Change Healthcare Inc (NASDAQ:CHNG) stock is ticking lower on a report that the U.S. Dept. of Justice is considering a…
Olema Oncology Receives FDA Fast Track Designation For OP-1250 For Treatment Of ER+ / HER2- Metastatic Breast Cancer
Olema Pharmaceuticals, Inc. ((&ldquo, Olema&rdquo, or &ldquo, Olema Oncology, &rdquo, NASDAQ:OLMA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to OP-1250, the